E3 PreliminaryPreliminaryPEM not requiredCase-ControlPeer-reviewedMachine draft
Standard · 3 min
Characterising DSCATT: A case series of Australian patients with debilitating symptom complexes attributed to ticks.
Schnall, Jesse, Oliver, Georgina, Braat, Sabine et al. · The Australian and New Zealand journal of psychiatry · 2022 · DOI
Quick Summary
Researchers studied 29 Australian patients who believed their symptoms were caused by tick bites. Most had severe tiredness, headaches, and joint pain, and many had previously been diagnosed with conditions like ME/CFS or fibromyalgia. When doctors tested these patients, they found no evidence of Lyme disease or other common infections from ticks. The study suggests that tick-attributed illness in Australia remains unexplained and may overlap with other medically unexplained conditions.
Why It Matters
This is the first systematic characterization of tick-attributed illness in Australia, directly relevant to ME/CFS research because of the high overlap in symptom profiles, diagnostic criteria, and classification as medically unexplained syndromes. Understanding how patients with similar debilitating symptoms are evaluated and managed across different diagnostic frameworks can inform research into shared mechanisms and improve diagnostic approaches for ME/CFS.
Observed Findings
Fatigue (83%), headache (72%), and arthralgia (69%) were the most frequently reported symptoms in the cohort.
No patient had serological evidence of acute Lyme disease or other common tick-borne infections despite clinical suspicion.
92% of patients (23/25) had previously received antimicrobials, with 53% reporting symptom benefit.
High rates of prior diagnoses of ME/CFS (28%), fibromyalgia (24%), and psychiatric comorbidities (anxiety 48%, depression 41%).
Hospital diagnoses reassigned most cases to ME/CFS (31%), migraines (28%), and fibromyalgia (21%), with only one case remaining unaccounted for.
Inferred Conclusions
DSCATT appears to be a medically unexplained syndrome with significant overlap to ME/CFS and fibromyalgia rather than a distinct tick-borne infectious disease.
No evidence supports acute Lyme disease or other common organic pathogens as the primary cause in Australian DSCATT cases.
The condition may represent an as-yet-unidentified biological cause, or may be conceptually similar to other medically unexplained syndromes.
The high rate of psychiatric comorbidity and prior antimicrobial response suggests complex, potentially multifactorial etiology.
Remaining Questions
What This Study Does Not Prove
This study does not prove that tick-attributed symptoms are psychosomatic or non-organic; the absence of evidence for known infections does not exclude novel pathogens, post-infectious sequelae, or biological processes not captured by current testing. The retrospective design and lack of control group limit causal inference about any relationship between tick exposure and symptom onset. Benefit from antimicrobials in some patients cannot establish infectious causation without controlled designs.
Tags
Symptom:Cognitive DysfunctionPainFatigue
Biomarker:Blood Biomarker
Phenotype:Infection-Triggered
Method Flag:Weak Case DefinitionNo ControlsSmall SampleExploratory OnlyMixed Cohort
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
What biological mechanisms, if any, link tick exposure to the reported symptom complex in patients with negative serology?
Does DSCATT represent a distinct disease entity or a heterogeneous group of patients with preexisting medically unexplained syndromes seeking attribution to an external cause?
Why do some patients report sustained benefit from antimicrobials despite negative serological testing for infectious agents?
How do symptom onset patterns, chronology of tick exposure, and temporal relationships to symptom development compare between DSCATT and ME/CFS cohorts?